Release Date: 25/10/10 10:15 Summary: Quarterly Activities and Cashflow Reports Price Sensitive: Yes Download Document 3.3MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%